Get the app!
Back to Trades
Grant4

BIOLIFE SOLUTIONS INC

BLFS

Total Value
$0

Company Information

Ticker Symbol
BLFS
CIK
0000834365

Insider Information

Role
Chief Technology Officer
Officer
Location
BOTHELL, WA

Filing Details

Filing Date
Feb 26, 2026
Transaction Date
Feb 24, 2026
Accession Number
0001628280-26-012471
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 24, 2026Common Stock24,116Grant/Award

Footnotes

  1. (F1)The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.